CYTEK BIOSCIENCES, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
CYTEK BIOSCIENCES, INC. (CTKB) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $1.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $976.00K, a 11.11% decline year-over-year.
- CYTEK BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $948.00K, a 6.05% decline year-over-year.
- CYTEK BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $1.15M, a 29.31% increase year-over-year.
- CYTEK BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $1.14M, a 19.21% increase year-over-year.
- CYTEK BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $4.40M, a 34.11% increase from fiscal 2024.
- CYTEK BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $3.28M, a 3.02% increase from fiscal 2023.
- CYTEK BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $3.18M, a 0.47% increase from fiscal 2022.
- CYTEK BIOSCIENCES, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $3.17M.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $976.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.92M 10-Q · filed 2026-08-05 | $3.07M derived: sum of 3 quarters · filed 2026-08-05 | $4.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $948.00K 10-Q · filed 2026-05-07 | $2.10M derived: sum of 2 quarters · filed 2026-05-07 | $3.24M derived: sum of 3 quarters · filed 2026-05-07 | $4.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.29M derived: sum of 2 quarters · filed 2026-02-26 | $3.39M derived: sum of 3 quarters · filed 2026-08-05 | $4.40M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.24M derived: sum of 2 quarters · filed 2026-08-05 | $3.25M 10-Q · filed 2025-11-05 | $4.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.11M 10-Q · filed 2026-08-05 | $2.99M derived: sum of 3 quarters · filed 2026-08-05 | $3.95M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.01M 10-Q · filed 2026-05-07 | $1.90M derived: sum of 2 quarters · filed 2026-05-07 | $2.85M derived: sum of 3 quarters · filed 2026-05-07 | $3.53M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $887.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.84M derived: sum of 2 quarters · filed 2026-02-26 | $2.52M derived: sum of 3 quarters · filed 2026-02-26 | $3.28M 10-K · filed 2026-02-26 |
| 2024-09-30 | $958.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.63M derived: sum of 2 quarters · filed 2025-11-05 | $2.39M 10-Q · filed 2025-11-05 | $3.19M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $672.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.43M 10-Q · filed 2025-08-06 | $2.23M derived: sum of 3 quarters · filed 2026-02-26 | $3.02M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $761.00K 10-Q · filed 2025-05-08 | $1.55M derived: sum of 2 quarters · filed 2026-02-26 | $2.35M derived: sum of 3 quarters · filed 2026-02-26 | $3.14M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $794.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.59M derived: sum of 2 quarters · filed 2026-02-26 | $2.38M derived: sum of 3 quarters · filed 2026-02-26 | $3.18M 10-K · filed 2026-02-26 |
| 2023-09-30 | $792.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.59M derived: sum of 2 quarters · filed 2024-11-07 | $2.39M 10-Q · filed 2024-11-07 | $3.49M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $796.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.60M 10-Q · filed 2024-08-06 | $2.70M derived: sum of 3 quarters · filed 2025-02-28 | $3.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $800.00K 10-Q · filed 2024-05-08 | $1.90M derived: sum of 2 quarters · filed 2025-02-28 | $2.60M derived: sum of 3 quarters · filed 2025-02-28 | $3.29M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.80M derived: sum of 2 quarters · filed 2025-02-28 | $2.49M derived: sum of 3 quarters · filed 2025-02-28 | $3.17M 10-K · filed 2025-02-28 |
| 2022-09-30 | $699.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.39M derived: sum of 2 quarters · filed 2023-11-14 | $2.06M 10-Q · filed 2023-11-14 | $2.06M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | $689.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.36M 10-Q · filed 2023-08-08 | $1.36M derived: sum of 3 quarters · filed 2024-03-13 | $1.36M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | $676.00K 10-Q · filed 2023-05-09 | $676.00K derived: sum of 2 quarters · filed 2024-03-13 | $676.00K derived: sum of 3 quarters · filed 2024-03-13 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $0.00 derived: sum of 2 quarters · filed 2024-03-13 | $0.00 10-K · filed 2024-03-13 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |